Despite an increased understanding of nicotine addiction, there is a scarcity of research comparing the neural correlates of non-drug reward between smokers and ex-smokers. Long-term changes in reward-related brain functioning for non-drug incentives may elucidate patterns of functioning that potentially contribute to ongoing smoking behaviour in current smokers. Similarly, examining the effects of previous chronic nicotine exposure during a period of extended abstinence may reveal whether there are neural correlates responsible for non-drug reward processing that are different from current smokers. The current study, therefore, sets out to examine the neural correlates of reward and loss anticipation, and their respective outcomes, in smokers, ex-smokers and matched controls using a monetary incentive delay task during functional magnetic resonance imaging. Here, we report that in the absence of any significant behavioural group differences, both smokers and ex-smokers showed a significantly greater activation change in the lateral orbitofrontal/anterior insular cortex compared with smokers when anticipating both potential monetary gains and losses. We further report that ex-smokers showed a significantly greater activation change in the ventral putamen compared with both controls and smokers and in the caudate compared with controls during the anticipation of potential monetary losses only. The results suggest that smoking may sensitize striato-orbitofrontal circuitry subserving motivational processes for loss avoidance and reward gain in nicotine addiction.
INTRODUCTION
Nicotine and other drugs of addiction are conceived to commandeer some of the same neural substrates that have evolved to support beneficial forms of synaptic plasticity, such as learning and memory (Gerdeman et al. 2003) . Laboratory studies in animals and humans have demonstrated nicotine-induced dopamine (DA) release within striatal regions of the brain (Domino et al. 2012) , which is believed to underlie nicotineˈs reinforcing properties (Tuesta, Fowler & Kenny 2011) . Striatal regions are also critical neuroanatomical substrates for the processing of non-drug rewards in humans (Knutson et al. 2001; OˈDoherty et al. 2006 ) and underlie incentive salience systems for goal objects (McClure, York & Montague 2004; Knutson et al. 2005) . Therefore, drugs such as nicotine, capable of engaging striatal 'reward circuitry', may potentially alter neural processing for non-drug rewards.
Disturbances in reward-related brain functioning for non-drug incentives may elucidate adaptations in neural circuitry that contribute to ongoing smoking behaviour in humans. The reward deficiency syndrome (RDS; Blum et al. 2000) and the allostatic hypotheses (Koob et al. 2004) , for example, view addiction as a deficit in DA motivational circuitry for non-drug incentives, such that only substances of abuse are able to normalize DA in fronto-striatal regions. The current, but limited, literature does suggest that chronic smokers have deficits in striatal DA integrity similar to other addiction populations (Fehr et al. 2008) and reduced reward-related neural activity for non-drug incentives (Rose et al. 2012) , appearing to concur with an RDS view of nicotine addiction. Substance-dependent groups, however, have also been shown to exhibit both impulsive and reward-centred choice behaviours, particularly involving an increased preference for small immediate over larger delayed nondrug rewards (Bechara et al. 2001) , suggesting some type of mesolimbic reward hyperactivity (Bickel et al. 2007) . Indeed, smokers (Martin et al. 2014) , cannabis users (Nestor, Hester & Garavan 2010; Filbey, Dunlop & Myers 2013) , alcoholics (Gilman et al. 2015; Grodin, Steckler & Momenan 2016) and even cocaine addicts in sustained abstinence (Balodis et al. 2016) have been reported to demonstrate hyperactivity in striatal regions during the pursuit of non-drug incentives. Previous and sustained substance use may also have a sensitizing effect in regions connected to, but outside, the striatum, such as the insular and orbitofrontal cortices, which represent motivational drive (Goldstein et al. 2007 ) and emotional and interoceptive states (Critchley et al. 2004; Terasawa, Fukushima & Umeda 2013) . This would appear to oppose the notion of an RDS in some addiction populations, instead suggesting heightened and indiscriminate neural responses to cues that signal all forms of potential reward.
While the majority of cigarette smokers endorse the desire to quit, reported abstinence rates after 12 months are in the modest region of 5-17 percent (Hughes, Peters & Naud 2008) , with the vast majority relapsing to smoking within a week of cessation (Zhu et al. 2012) . Executive functioning has been proposed to play a significant role in preventing relapse (Buhringer et al. 2008; Garavan et al. 2013) , and indeed, research has reported that long-term abstinent ex-smokers demonstrate hyperactivity in lateral and medial prefrontal regions that subserve inhibitory control functioning (Nestor et al. 2011; Kroenke et al. 2015 ). This appears to suggest that the emergence of prefrontal cognitive neural substrates is necessary for successful abstinence in addiction, although this does not preclude the existence of other mechanisms that may explicate changes in neural and behavioural functioning that protect against relapse.
Therefore, in order to examine the effects of both current and previous nicotine exposure on the behavioural and fronto-striatal correlates of non-drug incentives, we compared current smokers and ex-smokers and demographically matched healthy controls using a monetary incentive delay (MID) task. Specifically, we were interested in exploring (1) whether smokers and ex-smokers demonstrate shared or dissociated differences from controls in the neural response to the anticipation, and receipt, of monetary gains and losses in fronto-striatal networks and (2) whether such differences imply signs of either an RDS or reward-centred correlate in these regions during the pursuit of non-drug incentives.
MATERIAL AND METHODS

Participants
Fifteen current cigarette smokers, 10 ex-smokers and 15 controls completed the study. A semi-structured interview, as used in previous behavioural and functional imaging studies Carey et al. 2015) , was conducted to screen participants for past or present histories of psychiatric or neurological illness. Information pertaining to any form of treatment (counselling, psychological and psychiatric), past or present, was carefully detailed, with any potential participant describing any major lifetime psychiatric event or brain injury (e.g. head trauma resulting in a loss of consciousness, seizure or stroke) considered ineligible for the study. Participants were also considered ineligible if they reported any familial psychiatric history (i.e. sibling, parent or grandparent).
During the screening interview, all potential participants completed an inventory for drug use (questionnaire taken from the Addiction Severity Index Lite-CF; section on Questionnaires) to screen for past or concurrent abuse of substances; participants were considered ineligible if they reported concurrent or past dependence on other drugs (e.g. alcohol, amphetamines, barbiturates, benzodiazepines, cocaine, hallucinogens, MDMA and opiates). Information concerning alcohol and tobacco use in each participant was indexed in years (lifetime) and recently (last 30 days). Other drug use information for each participant was indexed by the total number of separate occasions (lifetime) and the total number of recent separate occasions (last 30 days).
Current smokers were required to have regularly consumed tobacco (≥10 cigarettes/day) for the previous 2 years in order to be eligible. Ex-smokers were required to have regularly consumed tobacco (≥10 cigarettes/ day) for at least 2 years, but be nicotine abstinent for at least 12 months at the time of testing. Ex-smokers were considered eligible if they additionally reported no past or current use of products to facilitate nicotine abstinence (e.g. gum, patches, lozenges, nasal spray and inhalators). Control participants were required to have never smoked cigarettes. Smoking abstinence in ex-smokers and controls was confirmed by measuring expired carbon monoxide in parts per million during the screening process. All participants in each of the three groups were required to provide a negative urine sample for various drugs of abuse on the day of testing, specifically screening for the presence of amphetamines, barbiturates, benzodiazepines, cannabinoids, cocaine, MDMA, methadone, opiates and tricyclic antidepressants (Cozart RapiScan, UK).
Because previous research has shown that acute abstinence from cigarettes impairs concentration (Heishman 1999; Newhouse, Potter & Singh 2004) and increases blood-oxygen-level-dependent (BOLD) activation changes during functional magnetic resonance imaging (MRI; Azizian et al. 2010) , cigarette smokers each smoked ad-lib approximately 15 minutes prior to scanning in order to avoid the potential confounds of withdrawal and/or craving on MID task performance.
Consequently, any differences in current smokers regarding task performance or BOLD activation changes could be attributable to the acute effects of their recent nicotine use. Given their frequent daily use, this is deemed desirable as it reveals the typical functioning of their neural systems.
All participants were right-handed as confirmed by the Edinburgh Handedness Inventory (Oldfield 1971) during the screening process. All participants completing the study were neurologically normal (as confirmed by a registered radiologist who examined each structural MRI). All research participants provided informed consent and were financially compensated.
Questionnaires
The National Adult Reading Test (Nelson & OˈConnell 1978) was administered to all participants during the screening procedure to assess verbal intelligence, as was the Beck Depression Inventory to assess mood (Beck, Steer & Brown 1996) . Information concerning alcohol and drug use (Table 1) was obtained from all participants using a questionnaire taken from the Addiction Severity Index Lite-CF (McLellan et al. 1992 ). During the screening procedure, the Fagerström Test of Nicotine Dependence (FTND) was administered to smokers. The FTND (Heatherton et al. 1991 ) is a six-item questionnaire that measures the degree of nicotine dependence in an individual smoker. We also administered the FTND to ex-smokers, retrospectively, in order to match their previous levels of nicotine dependence (when they were active smokers) to current smokers. The rationale for this was to eliminate previous dependency levels in ex-smokers as a potential contributing factor to neural differences with smokers.
The Shiffman-Jarvik smoking withdrawal questionnaire and the urge to smoke scale were administered to smokers prior to scanning. The 25-item Shiffman-Jarvik smoking withdrawal questionnaire (Shiffman & Jarvik 1976 ) asks individuals to respond to questions using a 7-point Likert-type scale that ranges from 'very definitely' (7) to 'very definitely not' (1) with respect to how they feel at that moment regarding separate withdrawal symptoms. These withdrawal symptoms are composed of craving, physical, psychological, sedation and appetite constructs. Each construct is given a mean score, with the mean for each construct summed to provide an overall withdrawal score for an individual. The 10-item urge to smoke scale (Jarvik et al. 2000) assesses responses to craving-related questions, using a 7-point Likert-type scale ranging from 'very definitely' (7) to 'very definitely not' (1).
Monetary incentive delay task
We used an 'MID task', which was based on that originally employed by Knutson et al. (2001) and which we Score prior to abstinence. NART = National Adult Reading Test; SEM = standard error of the mean. *P < 0.05 -control and ex-smoker < smoker.
have previously used to assess the neural correlates of reward processing in cannabis users . While being scanned, participants performed the MID task, during which they anticipated potential monetary gain, loss or no potential monetary outcome. During each trial, participants viewed one of three coloured squares (cue) that indicated the potential to gain 50 cents (green square), lose 50 cents (red square) or experience no financial outcome (blue square-here referred to as the neutral condition) following their response to an upcoming visual target. Each cue was presented for a variable duration (2-8 seconds), after which participants made a button press response upon the presentation of a visual target (star located within a circle). Participants received feedback (1500 milliseconds) following their response to the visual target, after which there was an end fixation period (2-8 seconds) before the commencement of the next trial. Responses to the visual target falling within ('hits') or outside ('misses') a 400-millisecond response deadline received feedback appropriate for that particular trial. We chose this 400-millisecond time frame in order to yield accuracy levels at~50 percent, which would serve to maintain the participantˈs interest in the task. Therefore, participants had 400 milliseconds to respond to the visual target in order to be successful on a gain, loss or neutral trial. There were a total of 27 trials in each condition (gain, loss and neutral), with each trial lasting between 6 and 18 seconds. The MID was composed of three runs, with each run lasting 340 seconds. The order of trials within each run was randomized. Dependent measures derived from the data included mean percentage accuracy and reaction time for the gain, loss and neutral conditions. The task was programmed and run using E-Prime version 1.1 (Psychology Software Tools, Pittsburgh, PA, USA).
Functional magnetic resonance imaging data acquisition
All scanning was conducted on a Philips Intera Achieva 3.0 Tesla MR system (Best, The Netherlands) equipped with a mirror that reflected the visual display, which was projected onto a panel placed behind the participantsˈ head outside the magnet. The mirror was mounted on the head coil in each participantˈs line of vision. Each scanning sequence began with a reference scan to resolve sensitivity variations. A parallel sensitivity encoding (SENSE) approach with a reduction factor of 2 was utilized for all T1-weighted image acquisitions (Pruessmann et al. 1999) . One hundred and eighty high-resolution T1-weighted anatomic MPRAGE axial images (FOV 230 mm, thickness 0.9 mm, voxel size 0.9 × 0.9 × 0.9) were then acquired (total duration 325 seconds), to allow subsequent activation localization and spatial normalization. Functional data were acquired using a T2* weighted echo-planar imaging sequence collecting 32 non-contiguous (10 percent gap) 3.5-mm axial slices covering the entire brain (TE = 35 milliseconds, TR = 2000 milliseconds, FOV 224 mm, 64 × 64 mm matrix size in Fourier space). Functional scans had a total duration of 340 seconds per run.
Functional magnetic resonance imaging data analyses
Data preprocessing and statistical analysis were conducted using FEAT (functional MRI Expert Analysis Tool) from the FMRIB Software Library (FSL 4.1, www.fmrib. ox.ac.uk/fsl). Pre-statistical processing was as follows: motion correction utilizing FMRIBˈs linear image registration tool, non-brain matter removal using brain extraction tool, spatial smoothing with a 6-mm full-width half maximum Gaussian kernel, mean-based intensity normalization and non-linear high-pass temporal filtering (Gaussian-weighted least squares straight line fit, with σ = 25.0 seconds). For each participant, first-level whole-brain mixed effects analyses were performed by modelling the MID anticipation periods (i.e. gain, loss and neutral) as explanatory variables within the context of the general linear model on a voxel-by-voxel basis (variable boxcar functions for the anticipation period regressors were convolved with the haemodynamic response function). The gain, loss and neutral outcome periods ('hit' and 'miss') were also modelled (stick functions for the feedback period regressors were convolved with the haemodynamic response function). The end fixation period of the task served as the implicit baseline. Registration was conducted through a two-step procedure, whereby echoplanar image (EPI) images were first registered to the high-resolution T1 structural image and then into standard (Montreal Neurological Institute, MNI avg152 template) space, with 12-parameter affine transformations.
As striatal and orbitofrontal regions are critical neural substrates for the processing of non-drug rewards in humans (Knutson et al. 2001; OˈDoherty et al. 2001) , with evidence for both hypoactivity and hyperactivity to non-drug rewards in these regions in addiction populations, we took an a priori region of interest (ROI) approach, restricting our search for group differences in these regions. These regions were taken from the Harvard-Oxford cortical and subcortical structural atlas and grouped together into one ROI mask (Fig S1) . Higher-level (between-group) analyses were conducted using FLAME (FMRIBˈs local analysis of mixed effects) on each of the gain, loss and neutral anticipation and outcome conditions. The end fixation period of the task served as the implicit baseline. Therefore, all reported differences between groups on the gain, loss and neutral conditions are for activation changes versus the baseline. Significant clusters in this ROI mask of a priori regions were determined by thresholding at Z > 2.3 with a corrected family-wise error cluster significance threshold of P < 0.05.
Other statistics
For analyses conducted on the MID behavioural data, we performed three (group: control versus ex-smoker versus smoker) by three (condition: neutral versus loss versus gain) analyses of variance. For further group analyses performed on the mean BOLD signal change, we conducted one-way analyses of variance. These analyses were all conducted using the Statistical Package for the Social Sciences (SPSS Inc., Chicago, IL, USA). Table 1 shows the demographic, smoking and alcohol use histories for the control, ex-smoker and smoker groups. The groups did not significantly differ on age, years of education, verbal intelligence, gender distribution or alcohol use history. The ex-smoker group had been abstinent from nicotine, on average, nearly 85 weeks (range: 52-180 weeks) at the time of testing. Figure 1a shows the mean MID accuracy (percent 'hits') for the three conditions in the three groups. A three (group: control versus ex-smoker versus smoker) by three (condition: neutral versus loss versus gain) analysis of variance showed that there was a significant effect of condition (F = 5.6; df = 111, 2; P < 0.01; neutral < loss, P < 0.05; neutral < gain, P < 0.01), but no group (F = 0.5; df = 111, 2; P = 0.6) or condition × group interaction (F = 0.09; df = 111, 4; P = 0.99). Figure 2b shows the mean MID reaction time (milliseconds) for the three conditions in the three groups. There was a significant effect of condition (F = 2.6; df = 111, 2; P < 0.05; loss < neutral, P < 0.09; gain < neutral, P < 0.05), no effect of group (F = 1.4; df = 111, 2; P = 0.3) and no condition × group interaction (F = 0.1; df = 111, 4; P = 1.0).
RESULTS
Demographics
Monetary incentive delay performance
Functional magnetic resonance imaging
We initially conducted mixed effects cluster-based oneway analyses of variance on the gain, loss and neutral conditions in the a priori ROI mask, but we were unable to find a group effect. Therefore, we combined the smoker and ex-smoker groups ('smokers') in order to increase sample size and performed cluster-based independent t-test analyses (control versus 'smokers') to examine activation differences on the anticipation and outcome periods in the ROI mask. For the loss anticipation condition (Fig. 2a) , 'smokers' showed significantly greater activation change in the right orbitofrontal/anterior insular cortex (OFC/AIC: 552 voxels, x = 44, y = 20, z = À6, Z = 4.1, P < 0.05), the right putamen (756 voxels, x = 20, y = 18, z = À8, Z = 3.65, P < 0.01) and the left caudate (734 voxels, x = À10, y = 8, z = 4, Z = 3.36, P < 0.01) compared with controls. Similarly, for the gain anticipation condition (Fig. 2b) , 'smokers' again showed significantly greater activation change in the right OFC/AIC (580 voxels, x = 46, y = 18, z = À10, Z = 3.63, P = 0.01), the right caudate (646 voxels, x = 10, y = 12, z = À2, Z = 3.94, P < 0.01) and the left putamen (620 voxels, x = À16, y = 8, z = À12, Z = 3.47, P < 0.01) compared with controls. There were no cluster-based analysis group differences that emerged for the neutral anticipation condition or on the gain, loss and neutral outcomes (hits and misses).
In order to assess whether the smoker and exsmoker groups had independently contributed to the loss and gain anticipation group differences, we extracted the mean BOLD signal change from each of the t-test clusters and conducted one-way (control Figure 1 Monetary incentive delay (MID) task performance in the control, ex-smoker and smoker groups for (a) mean percentage accuracy (loss > neutral, *P < 0.05; gain > neutral, **P < 0.01) and (b) mean reaction time (gain < neutral, **P < 0.05). Data were analysed using three (group: control versus ex-smoker versus smoker) by three (condition: neutral versus loss versus gain) analysis of variance. Data are expressed as means AE standard error of the mean versus ex-smoker versus smoker) analyses of variance. For the loss anticipation condition, there was a significant effect of group in the right OFC/AIC cluster (F = 6.6; df = 37, 2; P < 0.01; ex-smoker > control, P < 0.01; smoker > control, P < 0.05; Fig. 3a) , the right putamen cluster (F = 7.1; df = 37, 2; P < 0.01; ex-smoker > control, P < 0.001; ex-smoker > smoker, P < 0.05; Fig. 3b ) and left caudate cluster (F = 3.6; df = 37, 2; P < 0.05; ex-smoker > control, P < 0.05; Fig. 3c ). For the gain anticipation condition, there was a significant effect of group in only the right OFC/ AIC cluster (F = 4.4; df = 37, 2; P < 0.05; Figure 2 Initial Zt-statistical cluster maps generated by independent t-test analyses ('smokers' versus controls) in the a priori regions of interest for (a) loss anticipation and (b) gain anticipation showing that 'smokers' had significantly greater activation changes in orbitofrontal/anterior insular cortex and striatal regions compared with controls. Statistical images were first thresholded using clusters determined by Z > 2.3 with a corrected (family-wise error) cluster significance level of P < 0.05. The scale represents the colour (from dark to light yellow) of the cluster voxels corresponding to the increasing Zt-statistic. Co-ordinates are represented in Montreal Neurological Institute space Figure 3 Mean blood-oxygen-level-dependent (BOLD) signal change in the control, ex-smoker and smoker group showing that (a) ex-smokers (**P < 0.01) and smokers (*P < 0.05) had greater activation changes in the orbitofrontal/insular cortex compared with controls, (b) ex-smokers had greater activation changes in the putamen compared with both controls (*P < 0.001) and smokers (*P < 0.05), (c) ex-smokers (*P < 0.05) had greater activation changes in the caudate compared with controls during the loss anticipation condition and (d) ex-smokers and smokers had greater activation changes in the orbitofrontal/anterior insular cortex compared with controls (*P < 0.05) during the gain anticipation condition. Data were analysed using a one-way analysis of variance. Data are expressed as means AE standard error of the mean ex-smoker > control, P < 0.05; smoker > control, P < 0.05; Fig. 3d ).
Finally, we did not observe any differences in motion (mean absolute displacement in millimetres) between the groups (F = 1.4; df = 37, 2; P = 0.3; control 0.21 AE 0.03; smoker 0.28 AE 0.05; ex-smoker 0.29 AE 0.03) when acquiring the MID images.
Correlations
We did not find any significant correlations between smoking demographics in smokers and ex-smokers and mean percentage BOLD change values within the clusters where we observed group differences.
DISCUSSION
The present study examined loss and reward processing in cigarette smokers and demographically matched exsmokers and controls using an MID task. Behaviourally, we observed no significant differences between the three groups with respect to mean accuracy or reaction time. The absence of performance differences, therefore, enables us to discount performance-related effects (e.g. frustration) from confounding group comparisons with respect to the neural correlates of loss and gain anticipation. Furthermore, all three groups appeared to be equally incentivized to avoid losses and maximize gains, as revealed by the statistically significant differences in accuracy and response latencies compared with the neutral condition.
Greater orbitofrontal cortex activation during loss and gain anticipation in ex-smokers and smokers
The current study reports that during the anticipation of potential monetary losses and gains, smokers, and to a greater degree ex-smokers, had greater activation in the lateral OFC. There is evidence that neural responses in the lateral OFC reflect both implicit motivational value (Rothkirch et al. 2012 ) and incentive salience (Walter et al. 2010) , suggesting that these processes are heightened during both loss and gain anticipation in smokers and ex-smokers. These lateral OFC clusters also partially covered a region of the AIC. Importantly, the insular cortex is known to be involved in the evaluation of motivational states, reward, risk (Samanez-Larkin et al. 2007; Preuschoff, Quartz & Bossaerts 2008; Liu et al. 2011) and addiction relapse (Paulus, Tapert & Schuckit 2005; Naqvi et al. 2007; Seo et al. 2013) , with particular reference to its role in the awareness of interoceptive (i.e. bodily) states (Critchley et al. 2004) . Activations originating in the AIC (versus the lateral OFC) may further suggest that there is a disproportionate weighting of interoception in response to cues that signal non-drug rewards. This weighting may represent a sensitization of the insular cortex by previous nicotine exposure, which through its connections with the OFC represents a heightened motivational drive (Goldstein et al. 2007 ) and emotional and interoceptive state (Critchley et al. 2004; Terasawa et al. 2013 ) during non-drug reward expectancy.
The incentive sensitization theory of addiction proposes that sensitized neural circuits function to attribute incentive salience to reward-related stimuli, allowing reward cues to trigger excessive 'wanting' for the reward (Berridge & Robinson 1998 ). The focus of sensitized 'wanting' in addiction, however, is believed to be primarily towards drug cues and drug rewards, rather than natural rewards (Robinson & Berridge 2001) . Despite this contention, sensitization has been shown to enhance the pursuit of natural rewards in animals, where exposure to substances of abuse has been observed to significantly increase cue-elicited approach behaviour for non-drug rewards (Wyvell & Berridge 2001) . Interestingly, a similar effect has also been observed in humans, where the neural correlates of reward and loss anticipation are greater in cannabis users Filbey et al. 2013) , cigarette smokers (Martin et al. 2014) , alcoholics (Gilman et al. 2015; Grodin et al. 2016 ) and even cocaine addicts (Balodis et al. 2016) . This may suggest that chronic exposure to nicotine through smoking sensitizes striato-orbitofrontal circuitry that subserves motivational processes for loss avoidance and reward gain. Alternatively, the hyperactivity observed in 'smokers' may represent a trait-like effect that preceded smoking, but that has not 'corrected' with abstinence in the ex-smoker group.
Greater striatal activation in ex-smokers during loss anticipation
We also report that ex-smokers demonstrated a greater activation change in the ventral putamen compared with smokers and controls and compared with controls in the caudate during loss anticipation. Previous research has reported altered striatal activity for non-drug rewards in substance dependence (Wrase et al. 2007; Diekhof, Falkai & Gruber 2008; Buhler et al. 2010; Peters et al. 2011; Bustamante et al. 2014; Gradin et al. 2014) with some evidence for a sustained striatal RDS (Blum et al. 2000) in long-term substance abstinence. The current finding of increased ventral putamen and caudate activation in ex-smokers suggests that they have an increased motivational signal in a reward-motor network where preparatory responses might be optimized to avoid loss. Interestingly, this same sample of ex-smokers demonstrated reduced activation changes in the ventral striatum compared with smokers while viewing smoking stimuli (Nestor et al. 2011) , suggesting a neural shift in the attribution of salience between drug and non-drug predictive cues in the striatum during abstinence. This should be tempered, however, with the fact that differences between ex-smokers and smokers were smaller, possibly suggesting some similarities within a network of regions that function to integrate motivational drives (Goldstein et al. 2007 ) under conditions of loss avoidance.
Limitations of the current study involve small sample sizes, particularly in the ex-smoker group, and the lowmoderate nicotine dependency range in current smokers. The levels of dependency, for example, may reflect the young age of the smoker and ex-smoker groups, where a modest exposure to nicotine may have a sensitizing effect on brain circuitry subserving motivational and reward processes. These relatively modest levels of dependency, therefore, may curtail the generalizability of the current findings to greater levels of nicotine dependence that are observed in older adults (i.e. the confound between age and nicotine dependence). There may also have been a limitation of retrospectively recording previous dependency in our ex-smoker sample, given the large range of abstinence, potentially contributing to some inaccuracies in remembering. Furthermore, we were not able to make a direct comparison regarding the neural correlates of drug (smoking) and non-drug reward anticipation and outcome processing, which may limit how our findings can inform the relative importance of reward alterations in nicotine addiction. Imperfections of standard coregistration and normalization algorithms in FSL may also mean that the group differences reported in the lateral OFC may also have included a contribution from the AIC, which is implicated in addiction, particular relapse.
CONCLUSION
Despite the limitation of a small sample size (in particular, the ex-smoker group) and the low-moderate nicotine vdependency, the current study has provided preliminary evidence for hyperresponsive OFC processing during cueelicited approach behaviour for non-drug rewards in smokers and ex-smokers. This would appear to concur with the process of incentive sensitization, as opposed to the RDS, in the current sample. Therefore, we tentatively propose that smokers and ex-smokers have a neural substrate for predicting potential monetary losses and gains that represents a sensitization of striato-orbitofrontal circuitry integrating motivational drives and incentive salience for goal objects.
